AFCSX
Price
$19.13
Change
+$0.02 (+0.10%)
Updated
Oct 17 closing price
Net Assets
155.43M
RERAX
Price
$60.79
Change
-$0.26 (-0.43%)
Updated
Oct 17 closing price
Net Assets
137.72B
Interact to see
Advertisement

AFCSX vs RERAX

Header iconAFCSX vs RERAX Comparison
Open Charts AFCSX vs RERAXBanner chart's image
American Century Focused Intl Gr I
Price$19.13
Change+$0.02 (+0.10%)
VolumeN/A
Net Assets155.43M
American Funds EUPAC R1
Price$60.79
Change-$0.26 (-0.43%)
VolumeN/A
Net Assets137.72B
AFCSX vs RERAX Comparison Chart in %
View a ticker or compare two or three
VS
AFCSX vs. RERAX commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AFCSX is a Hold and RERAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RERAX has more cash in the bank: 138B vs. AFCSX (155M). RERAX pays higher dividends than AFCSX: RERAX (0.22) vs AFCSX (0.00). AFCSX was incepted earlier than RERAX: AFCSX (10 years) vs RERAX (23 years). RERAX (1.57) is less costly to investors than AFCSX (0.89). AFCSX is a more actively managed with annual turnover of: 82.00 vs. RERAX (35.00). RERAX has a lower initial minimum investment than AFCSX: RERAX (250) vs AFCSX (5000000). RERAX annual gain was more profitable for investors over the last year : 9.84 vs. AFCSX (7.71). AFCSX return over 5 years is better than : 11.78 vs. RERAX (9.42).
AFCSXRERAXAFCSX / RERAX
Total Expense Ratio0.891.5757%
Annual Report Gross Expense Ratio0.891.5757%
Fund Existence10 years23 years-
Gain YTD15.72920.54377%
Front LoadN/AN/A-
Min. Initial Investment50000002502,000,000%
Min. Initial Investment IRAN/AN/A-
Net Assets155M138B0%
Annual Yield % from dividends0.000.22-
Returns for 1 year7.719.8478%
Returns for 3 years46.1445.45102%
Returns for 5 years11.789.42125%
Returns for 10 yearsN/A35.44-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HALO67.030.15
+0.22%
Halozyme Therapeutics
TECTP10.82-0.03
-0.28%
Tectonic Financial
NTWK4.50-0.02
-0.44%
NetSol Technologies
GPCR27.38-0.18
-0.65%
Structure Therapeutics
RXT1.42-0.05
-3.40%
Rackspace Technology